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Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62 S43Results: Among the genes that were strongly upregulated on all 3 time
points after induction of CIOA were MMP-3 (6-fold), MMP-13 (16-fold),
MMP-14 (6-fold). Wound healing, phagocytosis, chemotaxis and met-
alloproteases were signiﬁcantly enriched, as were the complement
pathway, the TLR-, TGFb, BMP and wnt-signaling pathways. Highly
similar results were obtained in the DMM model for OA. However, at
day 42 in this model very view genes were still regulated in the syno-
vium compared to other time points or CIOA, indicating that synovial
activation differs late between the models. This was underlined by
histological examination, that shows thickened synovial lining mainly
in CIOA. All in all, the expression patterns in experimental OA showed
compelling similarities with human OA synovium. Gene expression
proﬁles of control synovia were compared to CHECK synovia. Analysis
using DAVID indicated enrichment of several biological processes and
signaling pathways, including macrophage presence, cell migration,
TGFb-, BMP- and wnt-signaling. This indicates clear activation of the
synovium in the CHECK patients compared to controls. Next we
compared synovial tissue of CHECK-patients with radiological damage
(KL1) with CHECK-patients without joint damage (KL¼0). In the top
30 genes that were associated with cartilage damage were MMP-1 (18-
fold), MMP-3 (10-fold) and S100A8 (6-fold), all of which have been
associated with cartilage damage. FAC analysis further underlined
response to wounding, chemotaxis, innate immune response and
metalloproteases to be strongly enriched. In particular, complement-
activation pathway, TGFb- and BMP-signaling and TLR-activation were
striking.
Conclusions: Activation pathways and processes in the two models for
OA were highly similar. A major difference lies in the presence of late
synovial activation. This may direct the choice for the most optimal
model to study certain OA subpopulations, since this difference was
obvious in human OA, where roughly 50% shows marked synovitis. The
FAC data suggest an active role for the synovium in OA pathology, and
identiﬁes pathways likely to be involved. One of the strongest associ-
ations was of the complement-pathway with cartilage damage. In
addition, synovial MMP expression was associated with cartilage
damage, underlining an active role of synovium in OA pathology.69
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Purpose: Osteophytes are signs of osteoarthritis (OA) that develop from
proliferating mesenchymal stem cells (MSCs) as bony outgrowths at the
margins of the joint. The synovium is one source of MSCs that can be
induced to undergo chondrogenesis and applied to regenerate articular
cartilage defects. Perlecan is a heparan sulfate proteoglycan present in
all basementmembranes and in the extracellular matrix of cartilage and
synovium. Perlecan interacts with other extracellular matrix proteins,
growth factors and receptors, and is implicated in cell growth, differ-
entiation, signaling, and stem cell maintenance.
We demonstrated that synovial perlecan is required for osteophyte
formation in a surgical OA model and a TGF-b-induced model using
perlecan-knockout mice (Hspg2-/--Tg) that we rescued from perinatal
lethality by transgenic perlecan expression in cartilage only (Ishijima et
al, Matrix Biology, 2012; Kaneko et al, OARSI 2011). We recently estab-
lished a primary mouse synovial cell culture method, in which mouse
synovial mesenchymal cells (SMCs) demonstrated both the ability to
proliferate andmulti-potentiality similar or superior to the cells derived
frommuscle or bonemarrow (Futami et al, PLOS One, 2012). The purpose
of the present study was to investigate the role of perlecan during
chondrogenic differentiation from synovial cells using established
primary mouse SMCs.
Methods: The primary SMCs were isolated by our established method
(Futami et al, PLOS One, 2012) from Hspg2-/--Tg and control Hspg2+/+-Tg
mice. To analyze cell growth kinetics, we plated synovial cells at passage4 at 1,000 cells/cm2 and cultured them for 14 days, counting cell
numbers with a hemocytometer every two days. We evaluated the
chondrogenic potential of SMCs in micromass cultures by both Alcian
blue staining and quantitative real-time PCR (qRT-PCR), performed in
RNA isolated at 3, 12, 72 hours, 1 and 2 weeks after chondrogenic
induction.
Results:We were able to isolate primary mouse SMCs from knee joints
of control and Hspg2-/--Tg mice. SMCs isolated from Hspg2-/--Tg mice
did not express perlecan, while those from control mice expressed
perlecan, as assessed by both immunohistochemical and qRT-PCR
analyses. SMCs cultures from control and Hspg2-/--Tg mice showed
similar proliferative potential in the absence of the chondrogenic
induction. However, during in vitro chondrogenic differentiation in
micromass culture, the cartilage matrix production detected by Alcian
blue staining in perlecan-deﬁcient SMCs was dramatically inhibited
compared to that in control SMCs. Accordingly, qRT-PCR analysis
demonstrated that the expression levels of Sox5, Sox9, Col2a1, Mmp13,
Adamts5, and Vegf mRNAs were also reduced during chondrogenic
differentiation in perlecan-deﬁcient SMCs compared to control SMCs.
Conclusions: This in vitro study showed that SMCs were viable and
proliferative, even in the absence of perlecan. On the other hand, when
SMCs were induced to undergo chondrogenesis, matrix production and
chondrogenic gene expressionwas impaired by the absence of perlecan.
Therefore, we conclude that perlecan is a prerequisite for chondrogenic
differentiation of SMCs.70
FACTORS ASSOCIATED WITH INCIDENT VARUS THRUST IN KNEE
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Purpose: Varus thrust can be visualized during gait as the dynamic
worsening or abrupt onset of varus alignment as the leg enters stance
phase, with a return to a more neutral alignment during toe-off and
swing phase. Varus thrust has been shown to be associated with a 4-
fold increase in the odds of medial tibiofemoral OA progression over an
18-month follow-up (Chang 2004). Varus thrust can develop at any
point during the disease process; factors associated with incident thrust
have not been identiﬁed. We hypothesized that varus alignment at
baseline is associated with incident varus thrust by 2 years later. In
addition to alignment, we sought to identify other baseline factors
associated with incident varus thrust, including: age, sex, BMI, race/
ethnicity, Physical Activity Scale for the Elderly (PASE) score, back pain
in past 30 days, previous knee injury limiting walking ability for 2
days, history of any knee surgery, knee extensor strength, and disease
severity.
Methods: The Osteoarthritis Initiative (OAI) is a prospective observa-
tional cohort study of incident and progressive knee OA. Observational
gait analysis by trained examiners at baseline (12 month) and 2 years
later (36 month visit) was used to assess varus thrust presence in OAI
participants. We categorized: BMI as normal (<25 kg/m2), overweight
(25-29.9), obese (30); race as White, African American, or other; knee
alignment as varus (deﬁned as>1 in the varus direction) or non-varus;
and disease severity as K/L 0-1, 2, or 3-4. To assess the relationship
between baseline factors and incident thrust by 2 years later, we used
multivariable logistic regression with GEE. The ﬁnal model was derived
using a backwards selection process that retained variables with p<0.2
from the initial full model with all baseline factors. Results are reported
as adjusted odds ratios (ORs) and 95% conﬁdence intervals (CIs); CIs that
exclude 1.0 are signiﬁcant at the 5% level.
Results: The sample included 4399 knees from 2909 persons [mean age
62 yrs ( 9, SD), BMI 28 kg/m2 (5), 59% women] who did not have
a varus thrust in either knee at baseline. At 2 years, 835 knees exhibited
a varus thrust. Age, knee injury, surgery, extensor strength, and PASE
did not meet criteria for inclusion in the ﬁnal model. The Table shows
the adjusted OR (95% CI) for each variable in the ﬁnal model. Varus
alignment, male sex, back pain, obese BMI (vs. normal BMI), and K/L
grades 2 and 3-4 (vs. K/L 0-1) were independently associated with an
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normal BMI) and race were not associated with incident thrust in the
ﬁnal model (Table 1).
Conclusions: Varus alignment at baseline, as well as male sex, back
pain, OA disease severity, and obesity, were independently associated
with increased odds of incident varus thrust by 2 years. A better
understanding of attributes associated with incident thrust may aid
ultimate development of strategies to prevent thrust.Table 1
Adjusted OR (95% CI) for Incident Varus Thrust by 2 Years
Baseline Factors Incident Varus Thrust by 2 Years
OR (95% CI) in Final Model*
Varus knee alignment 1.05 (1.02, 1.08)
Female 0.97 (0.94, 0.99)
Back pain, past 30 days 1.03 (1.001, 1.06)
K/L grade 2 1.04 (1.01, 1.07)
K/L grade 3 or 4 1.09 (1.04, 1.13)
Obese (BMI30) 1.05 (1.01, 1.09)
Overweight (BMI 25-29.9) 1.01 (0.98, 1.05)
African American race 1.04 (0.997, 1.08)
Other race 0.94 (0.88, 1.01)
*The initial model included baseline factors: knee alignment, age, sex, BMI, race/
ethnicity, PASE score, back pain, previous knee injury, previous knee surgery, knee
extensor strength, and K/L grade. Variables were retained (backward selection) for
the ﬁnal model if, in the initial model, p<0.2.
Table 1
Regression models of knee cartilage morphology
Dependent Variables Adjusted R2 p value
Medial tibial 5th percentile
thickness (mm)
BMI 0.014 0.213
BMI + PKAM 0.100 0.046*
Medial femur 5th percentile
thickness (mm)
BMI 0.105 0.019*
BMI + PKAM 0.182 0.007*
Medial tibial cartilage
volume (mm3)
BMI 0.014 0.848
BMI + KAM Impulse 0.060 0.052
Medial tibial surface
area (mm2)
BMI 0.012 0.227
BMI + KAM Impulse 0.151 0.017*
Medial femur surface
area (mm2)
BMI 0.017 0.561
BMI + KAM Impulse 0.072 0.036*
BMI ¼ Body Mass Index (kg/m2).
PKAM ¼ Peak Knee Adduction Moment (Nm/kg).
KAM Impulse ¼ Knee Adduction Moment Impluse (Nm*s).
*p<0.05.71
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Purpose: The peak knee adduction moment (KAM), a surrogate for the
maximum medial knee load, predicts radiographic progression of knee
osteoarthritis (OA). However, alone, it does not correlate consistently
with mean cartilage thickness. The KAM impulse accounts for both the
magnitude and duration of loading. The number of steps per day is an
indicator of loading frequency. The objective of this study was to
determine the extent to which variation in peak KAM, KAM impulse,
and loading frequency can explain variation in medial cartilage thick-
ness, volume, and surface area in the femur and tibia.
Methods: Forty-three participants (age: 61.1  6.3 years; Body Mass
Index (BMI): 28.6  5.9 kg/m^2) who met the ACR clinical criteria for
knee OAwere recruited. Rigid, infraredmarker clusters were secured on
the sacrum, thigh, shank and foot of the study leg and tracked using
Optotrak position sensors (Certus, Northern Digital Inc, Waterloo,
Canada). The study leg corresponded to the side with the most severe
symptoms. Ground reaction forces were recorded using embedded
force plates (AMTI, Watertown, MA, USA). Participants performed 5
barefoot walking trials at self-selected speed. The KAM waveform was
generated using inverse dynamics (Visual 3D, C-Motion, Inc., German-
town, MD, USA). The mean non-normalized KAM impulse over ﬁve
trials was calculated and mean number of steps/day was measured over
5 days using an accelerometer.Within 1 week of the biomechanical data
collection, each participant underwent an MRI scan of the study knee
using a 1T peripheral MRI scanner (GE Healthcare, USA). Medial tibial
and femoral cartilage morphometry was segmented from images ob-
tained from a coronal 3D SPGRE fat-saturated sequence (1.5 mm
thickness) using a highly automated, atlas-based method (Qmetrics,
Rochester, NY, USA). Sequential forward linear regressions were per-
formed for each of the following dependent variables for the medial
compartment cartilage in the tibia and femur: mean and 5th percentile
thickness, volume, and surface area. Two regressions were performed
for each dependent variable: the ﬁrst with BMI and peak KAM as
separate independent variables and the second with BMI, KAM impulse,
and steps/day entered as separate independent variables.
Results: Table 1 summarizes the regression models. BMI and the peak
KAM explained (i) 10.0% of variance in 5th percentile cartilage thickness
in the medial tibia and (ii) 18.2% of variance in 5th percentile cartilagethickness in the medial femur. As well, BMI and the KAM impulse
explained (i) 6% of variance in medial tibial cartilage volume, (ii) 15.1%
of variance in surface area of the bone-cartilage interface in the medial
tibia and (iii) 7.2% of variance in surface area of the bone-cartilage
interface in the medial femur.
Conclusions: After accounting for obesity, the maximum load incurred
by the medial knee compartment at a single time point was implicated
in focal thinning in the tibia and femur. Meanwhile, the KAM impulse,
reﬂecting both the magnitude and duration of knee loads during gait,
related to the surface area of the bone-cartilage interface in the tibia and
femur. These ﬁndings add to previous work that has demonstrated
a crude measure of total joint load, obesity, is directly related to the size
of the knee articular surface area.72
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Background: Total knee arthroplasty (TKA) is the most common
treatment for end-stage knee OA, with approximately 500,000 proce-
dures performed each year in the United States. The number of proce-
dures is expected to rise to over threemillion by 2030 due to population
growth, increasing longevity and a rise in obesity. There have been
numerous studies on the operated knee before and after unilateral TKA,
but there have been fewer studies on the non-operated knee. There is
evidence of non-random progression of OA in the other lower limb
joints after unilateral TKA, with the non-operated knee being at the
greatest risk for OA progression and another TKA.
Recent biomechanical studies suggest one reason for the higher rate of
OA progression may be limb asymmetry postoperatively, in which the
non-operated knee bears greater loads postoperatively than the oper-
ated knee. It is unclear, however, whether this is a result of gait changes
due to the surgery itself. The present study aimed to examine the
preoperative and postoperative biomechanics of the non-operated knee
in the frontal plane to determine if gait patterns worsen after surgery.
Methods: Fifty patients were examined before and two months after
TKA. Patients underwent a 3D gait analysis using the Vicon Motion
Analysis system (Oxford Metrics Ltd., Oxford, UK) and completed a VAS
scale for pain. Data from both the operated and non-operated knees
were analyzed and compared. Data were compared to a healthy control
group using ﬁndings from previously published studies.
Results: The study results are presented in Table 1. The non-operated
knee did not show signiﬁcant changes in knee varus angle (KVA)
(Figure 1) or knee adduction moment (KAM) (Figure 2) after surgery (all
p>0.05). Pain in the non-operated knee did not improve signiﬁcantly
after surgery (p¼0.066). Changes were not found in spatiotemporal
parameters unique to the non-operated knee after surgery. In
comparison to the operated knee, the non-operated knee showed
similar KVA and KAM preoperatively, but higher KVA and KAM
